Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Bayer Limited, 1st Floor, The Grange Offices, The Grange, Brewery Road, Stillorgan, Co Dublin, A94 H2K7, Ireland
Yasmin 0.03 mg / 3 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. Light yellow, round tablets with convex faces, one side marked with the letters “DO” in a regular hexagon. |
Each film-coated tablet contains 0.030 mg ethinylestradiol and 3 mg drospirenone.
Excipient with known effect: lactose 46 mg (as lactose monohydrate 48.17 mg).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| 17 alpha-Ethinylestradiol |
Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
|
| Drospirenone |
Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Tablet coating: Hypromellose |
PVC/Aluminium blister pack.
Pack sizes:
21 tablets
3x21 tablets
6x21 tablets
13x21 tablets
Not all pack sizes may be marketed.
Bayer Limited, 1st Floor, The Grange Offices, The Grange, Brewery Road, Stillorgan, Co Dublin, A94 H2K7, Ireland
PA1410/023/001
Date of first authorisation: 27 October 2000
Date of last renewal: 7 March 2015
| Drug | Countries | |
|---|---|---|
| YASMIN | Austria, Brazil, Canada, Cyprus, Ecuador, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
